Bernie Sanders has released his plan for cannabis legalization, which features provisions to keep Big Tobacco from colonizing the new industry. But other exponents of corporate power are already getting a jump on the cannabis sector, and could just as effectively squeeze out independent operators.

With the legal cannabis market increasingly dominated by "Big Bud," more Canadians are turning to homegrown—both for reasons of economy and an ethic of self-sufficiency. And they are fighting in the courts and the public squares for their right to do so—challenging both the federal limit on plants per household and efforts by two provinces to ban homegrown outright. So far, they are winning.
Cannabis is turning into a key issue testing the limits of First Nations sovereignty in Canada—right up there with the long-standing struggles over oil, mineral, timber and hydro-electric development. At least one First Nation is operating a cannabis outlet without provincial authorization, in a direct challenge to authorities. And if accommodations are not reached with provincial and federal regulators, more may be set to follow.
New York state's second city of Buffalo has long been a national symbol of rust-belt economic and infrastructural decay. Now urban planners have approved a massive cannabis facility backed by California capital for the city's long-inactive waterfront. Buffalo's boosters say the project could turn the Great Lakes region into a leading global hub of cannabis output.
In a strange irony, Vancouver is shutting down its long-tolerated but unlicensed cannabis dispensaries, pursuant to a British Columbia high court decision upholding its right to do so—even as the province struggles to meet demand amid a dearth of licensed retail outlets.
From the "Tulip Mania" in 15th century Holland to the Bitcoin bubble of 2017, high hopes for a commodity's market performance can lead to unsustainable overvaluation inevitably followed by a painful correction. Many observers believe that cannabis fell prey to this phenomenon in 2018—but are hoping for growth in a more rational and realistic market in the coming year.
Amid the seemingly endless hype about CBD, its once better-known sibling cannabinoid THC seems to increasingly languish in the shadows—both in terms of media attention and industry investment.





Recent comments
2 weeks 3 days ago
3 weeks 1 day ago
13 weeks 1 day ago
17 weeks 1 day ago
18 weeks 2 days ago
18 weeks 2 days ago
39 weeks 2 days ago
43 weeks 3 days ago
45 weeks 23 hours ago
45 weeks 1 day ago